These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16539632)

  • 1. Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients.
    Carter JT; Melcher ML; Carlson LL; Roland ME; Stock PG
    Am J Transplant; 2006 Apr; 6(4):753-60. PubMed ID: 16539632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of kidney transplantation in HIV-infected recipients.
    Stock PG; Barin B; Murphy B; Hanto D; Diego JM; Light J; Davis C; Blumberg E; Simon D; Subramanian A; Millis JM; Lyon GM; Brayman K; Slakey D; Shapiro R; Melancon J; Jacobson JM; Stosor V; Olson JL; Stablein DM; Roland ME
    N Engl J Med; 2010 Nov; 363(21):2004-14. PubMed ID: 21083386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experience.
    Trofe J; Stratta RJ; Egidi MF; Lo A; Gaber LW; Shokouh-Amiri MH; Grewal HP; Honaker M; Hardinger K; Alloway RR; Gaber AO
    Clin Transplant; 2002; 16 Suppl 7():34-44. PubMed ID: 12372042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose Thymoglobulin vs Basiliximab Induction Therapy in Low-Risk Living Related Kidney Transplant Recipients: A Prospective Randomized Trial.
    Martinez-Mier G; Moreno-Ley PI; Budar-Fernández LF; Méndez-López MT; Allende-Castellanos CA; Jiménez-López LA; Barrera-Amoros DA; Aguilar-Sandoval E; De la Paz-Román M; Soto-Miranda E; Rivera-Sanchez Y; Martínez-Maldonado M
    Transplant Proc; 2021 Apr; 53(3):1005-1009. PubMed ID: 32178925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of thymoglobulin and basiliximab in kidney transplant patients at high risk for acute rejection and delayed graft function.
    Chen G; Gu J; Qiu J; Wang C; Fei J; Deng S; Li J; Huang G; Fu Q; Chen L
    Exp Clin Transplant; 2013 Aug; 11(4):310-4. PubMed ID: 23121641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients.
    Peddi VR; Bryant M; Roy-Chaudhury P; Woodle ES; First MR
    Transplantation; 2002 May; 73(9):1514-8. PubMed ID: 12023634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of thymoglobulin induction on HIV-infected renal transplant recipients: differences between HIV-positive and HIV-negative patients.
    Trullas JC; Cofan F; Cocchi S; Cervera C; Linares L; Aguero F; Oppenheimer F; Moreno A; Campistol JM; Miró JM
    AIDS Res Hum Retroviruses; 2007 Oct; 23(10):1161-5. PubMed ID: 17961099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretransplant CD4 Count Influences Immune Reconstitution and Risk of Infectious Complications in Human Immunodeficiency Virus-Infected Kidney Allograft Recipients.
    Suarez JF; Rosa R; Lorio MA; Morris MI; Abbo LM; Simkins J; Guerra G; Roth D; Kupin WL; Mattiazzi A; Ciancio G; Chen LJ; Burke GW; Goldstein MJ; Ruiz P; Camargo JF
    Am J Transplant; 2016 Aug; 16(8):2463-72. PubMed ID: 26953224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term outcomes of Thymoglobulin induction in pediatric renal transplant recipients.
    Ault BH; Honaker MR; Osama Gaber A; Jones DP; Duhart BT; Powell SL; Hays DW; Wyatt RJ
    Pediatr Nephrol; 2002 Oct; 17(10):815-8. PubMed ID: 12376809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin.
    Libório AB; Mendoza TR; Esmeraldo RM; Oliveira ML; Paes FJ; Silva Junior GB; Daher EF
    Int Immunopharmacol; 2011 Nov; 11(11):1832-6. PubMed ID: 21835269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of anti-T-cell therapy in the immunogenicity of seasonal influenza vaccine in kidney transplant recipients.
    Orcurto A; Pascual M; Hoschler K; Aubert V; Meylan P; Manuel O
    Transplantation; 2012 Sep; 94(6):630-6. PubMed ID: 22895612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of Different Induction Regimes on Serial Lymphocyte Subsets in Kidney Transplant Recipients: A Single Tertiary Center Experience.
    Jalalonmuhali M; Ng KP; Lee YW; Gan CC; Hing Wong A; Wan Md Adnan WAH; Cheng SF; Chew CC; Ooi SH; Wong CM; Lim SK
    Transplant Proc; 2022 Mar; 54(2):299-306. PubMed ID: 35181166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of low and ultra-low dosages Thymoglobulin on peripheral T, B and NK cells in kidney transplant recipients.
    Kho MM; Bouvy AP; Cadogan M; Kraaijeveld R; Baan CC; Weimar W
    Transpl Immunol; 2012 Jun; 26(4):186-90. PubMed ID: 22410573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients.
    Brennan DC; Flavin K; Lowell JA; Howard TK; Shenoy S; Burgess S; Dolan S; Kano JM; Mahon M; Schnitzler MA; Woodward R; Irish W; Singer GG
    Transplantation; 1999 Apr; 67(7):1011-8. PubMed ID: 10221486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between thymoglobulin and ATGAM as an induction agent in adult kidney transplantation: a single-center experience.
    Kim JM; Jang HR; Ko JS; Kwon CH; Kwak MS; Hur WS; Kim SJ; Kim GS; Joh JW; Lee SK; Oh HY
    Transplant Proc; 2012 Jan; 44(1):171-4. PubMed ID: 22310607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymoglobulin and its use in renal transplantation: a review.
    Thiyagarajan UM; Ponnuswamy A; Bagul A
    Am J Nephrol; 2013; 37(6):586-601. PubMed ID: 23774740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of efficacy and safety between rabbit anti-thymocyte globulin and anti-T lymphocyte globulin in kidney transplantation from donation after cardiac death: a retrospective cohort study.
    Chen GD; Lai XQ; Ko DS; Qiu J; Wang CX; Han M; Li J; Huang G; He XS; Chen LZ
    Nephrology (Carlton); 2015 Aug; 20(8):539-43. PubMed ID: 25808082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymoglobulin versus ATGAM induction therapy in pediatric kidney transplant recipients: a single-center report.
    Khositseth S; Matas A; Cook ME; Gillingham KJ; Chavers BM
    Transplantation; 2005 Apr; 79(8):958-63. PubMed ID: 15849550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-day induction with thymoglobulin in kidney transplantation: risks and benefits.
    Uslu A; Nart A; Coker I; Köse S; Aykas A; Kahya MC; Yüzbaşioğlu MF; Doğan M
    Transplant Proc; 2004; 36(1):76-9. PubMed ID: 15013305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.
    Gaber AO; First MR; Tesi RJ; Gaston RS; Mendez R; Mulloy LL; Light JA; Gaber LW; Squiers E; Taylor RJ; Neylan JF; Steiner RW; Knechtle S; Norman DJ; Shihab F; Basadonna G; Brennan DC; Hodge EE; Kahan BD; Kahan L; Steinberg S; Woodle ES; Chan L; Ham JM; Schroeder TJ
    Transplantation; 1998 Jul; 66(1):29-37. PubMed ID: 9679818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.